Trial NCT04357808
Publication SARCOVID, Unpublished, 2021 ( )
Dates: 2020-04-13 to 2020-10-30
Funding: Mixed (Rosario Garcia de Vicuna Rheumatology Service University Hospital La Princesa, Sanofi provides medication for the intervention arm sarilumab (Kevzara, 40 prefilled syringes). Funds for a data manager are subject to achievement of predefined milestones throughout the study. Sanofi has no role in the design of the study and data collection, analysis, and interpretation of data and in writing the manuscript.)
Conflict of interest: No